Work

Cost-effectiveness analysis of p53 immunohistochemical testing in stage I and II high-risk endometrial cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e18838

Authors: Taylor Orellana, Jessica L. Berger, Michelle M. Boisen, Ronald J. Buckanovich, Lan Gardner Coffman, Madeleine Courtney-Brooks, Robert P. Edwards, Haider Mahdi, Alexander Olawaiye, Paniti Sukumvanich, John Vargo, Rohit Bhargava, Sushil Beriwal, Sarah E. Taylor, Kenneth Smith, Jamie Lee Lesnock

Institutions: Magee-Womens Hospital, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, University of Pittsburgh

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3167777847

Cites:

Cited by:

Related to: 10